TrivarX Engages CRO for Stabl-Im Phase 1 Safety Trial

TrivarX Limited (ASX: TRI), a healthcare technology company focused on developing innovative diagnostic and imaging solutions across mental health and neuro-oncology, has announced a significant step forward in the clinical development of its Stabl-Im imaging technology. The company has engaged The post TrivarX Engages CRO for Stabl-Im Phase 1 Safety Trial first appeared on Sharecafe .